RxDoctor Payments Data

Alexander Yeh, DO

Family Medicine · Westerville, OHNPI 1619241684

Payments from drug & device makers

$1,020in general payments, 2019–2025

Across 50 payments — averaging $20.40 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$190
  • AbbVie$147
  • GSK$105
  • Novo Nordisk$97
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$81
  • Pfizer$79
  • plus $320 from 10 others

What the payments were for

  • Food & beverage$97095%
  • Other$505%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,020 in reported general payments places this provider in the 60th percentile of 3,983 family medicine providers in Ohio.

See all family medicine providers in Ohio

Medicare billing

Part B allowed, 2024
$35,946
Medicare patients
123
Services billed
579

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide123$130,185
TrulicityDulaglutide78$89,963
JardianceEmpagliflozin60$60,590
EliquisApixaban51$37,778
MounjaroTirzepatide34$34,800
VraylarCariprazine Hcl14$19,367
FarxigaDapagliflozin Propanediol19$18,504
MyrbetriqMirabegron26$16,904
Combivent RespimatIpratropium/Albuterol Sulfate20$16,580
Trelegy ElliptaFluticasone/Umeclidin/Vilanter16$15,047
OxycontinOxycodone Hcl12$14,087
TrintellixVortioxetine Hydrobromide15$11,457
Lantus SolostarInsulin Glargine,hum.Rec.Anlog81$10,948
Repatha SureclickEvolocumab11$10,409
LinzessLinaclotide13$7,516

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$97$130,185123 claims
Lilly USA, LLCTrulicity, Mounjaro$12$124,763112 claims
PfizerEliquis$79$37,77851 claims
AbbVieVraylar, Linzess$147$26,88327 claims
AstraZenecaFarxiga, Symbicort$190$24,48537 claims
Astellas Pharma US IncMyrbetriq$23$16,90426 claims
GSKTrelegy Ellipta$105$15,04716 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 3,983 family medicine providers in Ohio.

Other family medicine in Westerville

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →